Drug Shortage Report for NAT-LEVETIRACETAM

Last updated on 2021-10-15 History
Report ID 81921
Drug Identification Number 02440229
Brand name NAT-LEVETIRACETAM
Common or Proper name LEVETIRACETAM Tablets
Company Name NATCO PHARMA (CANADA) INC
Market Status MARKETED
Active Ingredient(s) LEVETIRACETAM
Strength(s) 750MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 120
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date 2019-08-01
Actual start date
Estimated end date
Actual end date 2021-10-14
Shortage status Resolved
Updated date 2021-10-15
Company comments
Health Canada comments
Contact Address 2000 ARGENTIA ROAD, PLAZA 1, SUITE 200
MISSISSAUGA, ONTARIO
CANADA L5N 1P7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2021-10-15 English Compare
v7 2021-10-14 French Compare
v6 2021-10-14 English Compare
v5 2021-10-14 French Compare
v4 2021-10-14 English Compare
v3 2019-08-02 English Compare
v2 2019-04-17 French Compare
v1 2019-04-17 English Compare